DETECTION OF DRUG-RELATED PROBLEMS IN ANTIMICROBIALS

被引:0
作者
Penarrubia Rodrigo, Bonilla [1 ]
Monsalve Ana, Garcia [1 ]
Alonso Pilar, Campillos [1 ]
Salom Pedro, Garcia [1 ]
机构
[1] Hosp Vega Baja, Serv Farm, Alicante, Spain
来源
ATENCION FARMACEUTICA | 2009年 / 11卷 / 03期
关键词
PHARMACEUTICAL CARE; ANTIMICROBIALS; DRUG-RELATED PROBLEMS (DRP); LENGTH-OF-STAY; PHARMACEUTICAL CARE; COST; PHARMACIST; IMPACT; EVENTS; MORBIDITY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: The purpose of this study is to analyze drug-related problems (DRP) and pharmaceutical interventions being perfromed regarding antimicrobial therapy in a county hospital, as well as the results of such interventions on the patient. Method: We collected prospective information of all pharmaceutical interventions performed and the detected drug-related problems in antibiotic treatment for patients of a 360-bed county hospital for a 6-month period. The DRP were catalogued according to the Granada consensus' classification and ranked by severity type. For every detected DRP we performed an intervention and reported whether the proposal was accepted or rejected by the physician, as well as the adequacy of such action and results on the patient. Results: During the period of study, we detected 83 DPR that produced 83 interventions. According to the DRP classification based on the Granada consensus, among all the detected DRP, 13 were related to the indication, 31 to effectiveness and 39 to safety. The most frequently identified DRPs were linked to dosage: too high dose (40%) and too low dose (35%). Among the detected DRP 55 had reached the patient (real error), while 28 were potential errors. Of all the performed interventions (n = 83), 62 were accepted (74.7%), while 15 were rejected (18.1%). The remaining 6 were of unknown result. Conclusions: The dedication of a pharmacist to the hospitalized patient pharmacotherapeutic follow-up with the purpose of preventing, identifying and resolving DRP that may interfere in achieving positive therapeutic results produces a qualitative improvement in the overall care process. In order to optimize the pharmaceutical care process, some improvements could be made to the system such as integrating the pharmacist in a multidisciplinary team and implementing an electronic prescription system.
引用
收藏
页码:181 / 189
页数:9
相关论文
共 44 条
[1]  
Alonso Hernandez P., 2002, FARM HOSP, V26, P77
[2]  
[Anonymous], 2007, ARS PHARM, V48, P5
[3]  
[Anonymous], 1999, To err is human: building a safer health system
[4]  
Baena MI., 2001, Pharm Care Esp, V3, P345
[5]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[6]   The costs of adverse drug events in hospitalized patients [J].
Bates, DW ;
Spell, N ;
Cullen, DJ ;
Burdick, E ;
Laird, N ;
Petersen, LA ;
Small, SD ;
Sweitzer, BJ ;
Leape, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :307-311
[7]   Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals [J].
Bond, CA ;
Raehl, CL ;
Franke, T .
PHARMACOTHERAPY, 2000, 20 (06) :609-621
[8]   Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital [J].
Boyko, WL ;
Yurkowski, PJ ;
Ivey, MF ;
Armitstead, JA ;
Roberts, BL .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (14) :1591-1595
[9]  
CABEZAS MCL, 2002, FARM HOSP, V26, P215
[10]  
Castillo I., 2000, FARM HOSP, V24, P27